B-cell Chronic Lymphocytic Leukemia
B-cell Chronic Lymphocytic Leukemia (CLL) is a type of cancer that affects the blood and bone marrow, characterized by the overproduction of abnormal B lymphocytes, which can lead to various health complications.
Chronic Lymphocytic Leukemia: CAP-100 Treatment
We are testing a new treatment called CAP-100 for patients with relapsed or refractory chronic lymphocytic leukemia. The study aims to assess how safe and tolerable this treatment is.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Hospital Universitario De La Princesa
Hematology
Ciudad Lineal, Spain
Hospital Universitario Marques De Valdecilla
Hematology
Santander, Spain
Complexo Hospitalario Universitario De Santiago
Hematology
Santiago de Compostela, Spain
Sponsor: Catapult Therapeutics B.V.
Last updated: Nov 27, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.